Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-09-13 Purchase |
2022-09-14 5:16 pm |
SAB Biotherapeutics Inc. | SABS | HAMILTON CHRISTINE E Director 10% Owner |
10,000 | $0.7297 | $7,297 | 4,993,090 (Direct) |
View |
| 2022-09-07 Purchase |
2022-09-08 4:31 pm |
SAB Biotherapeutics Inc. | SABS | Sullivan Eddie Joe CHIEF EXECUTIVE OFFICER 10% Owner |
14,000 | $0.7368 | $10,315 | 5,230,564 (Direct) |
View |
| 2021-10-26 Sale |
2021-11-16 3:09 pm |
SAB Biotherapeutics Inc. | SABS | Beyer Russell P Chief Financial Officer |
278 | $7.9 | $2,196 | 2,490 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-03-14 Option Award |
2023-03-16 4:30 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Kropotova Alexandra Chief Medical Officer |
275,000 | $0 | 275,000 (Direct) |
View |
| 2023-03-14 Option Award |
2023-03-16 4:29 pm |
N/A 2033-03-14 |
SAB Biotherapeutics Inc. | SABS | Sullivan Eddie Joe Chief Executive Officer |
525,000 | $0 | 525,000 (Direct) |
View |
| 2023-03-14 Option Award |
2023-03-16 4:28 pm |
N/A 2033-03-14 |
SAB Biotherapeutics Inc. | SABS | Reich Samuel J Executive Chairman |
525,000 | $0 | 525,000 (Direct) |
View |
| 2023-03-14 Option Award |
2023-03-16 4:28 pm |
N/A 2033-03-14 |
SAB Biotherapeutics Inc. | SABS | Bausch Christoph Lawrence Chief Operating Officer |
275,000 | $0 | 275,000 (Direct) |
View |
| 2023-03-14 Option Award |
2023-03-16 4:27 pm |
N/A 2033-03-14 |
SAB Biotherapeutics Inc. | SABS | Beyer Russell P Chief Financial Officer |
275,000 | $0 | 275,000 (Direct) |
View |
| 2023-02-28 Other |
2023-03-02 09:20 am |
2022-01-14 2026-10-20 |
SAB Biotherapeutics Inc. | SABS | Spragens Jeffrey G Director |
19,936 | $0 | 19,936 (Direct) |
View |
| 2023-02-28 Other |
2023-03-02 09:18 am |
2022-01-14 2026-10-20 |
SAB Biotherapeutics Inc. | SABS | Reich Samuel J Executive Chairman |
218,568 | $0 | 9,968 (Indirect) |
View |
| 2022-06-07 Ownership |
2023-02-10 4:14 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | HAMILTON CHRISTINE E Director 10% Owner |
2,000,000 | $0 | 8,101,360 (Indirect) |
View |
Ownership |
2023-02-10 4:14 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | HAMILTON CHRISTINE E Director 10% Owner |
0 | $0 | 8,101,360 (Indirect) |
View |
| 2022-12-07 Option Award |
2022-12-09 4:31 pm |
2023-06-07 2027-12-07 |
SAB Biotherapeutics Inc. | SABS | HAMILTON CHRISTINE E Director 10% Owner |
82,987 | $0 | 8,187,411 (Indirect) |
View |
| 2022-12-07 Option Award |
2022-12-09 4:31 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | HAMILTON CHRISTINE E Director 10% Owner |
82,987 | $1.205 | 8,187,411 (Indirect) |
View |
| 2022-12-07 Option Award |
2022-12-09 09:02 am |
2023-06-07 2027-12-07 |
SAB Biotherapeutics Inc. | SABS | Spragens Jeffrey G Director |
82,987 | $0 | 477,976 (Direct) |
View |
| 2022-12-07 Option Award |
2022-12-09 09:02 am |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Spragens Jeffrey G Director |
82,987 | $1.205 | 477,976 (Direct) |
View |
| 2022-12-07 Option Award |
2022-12-09 09:01 am |
2023-06-07 2027-12-07 |
SAB Biotherapeutics Inc. | SABS | Link David Charles Director |
41,493 | $0 | 98,806 (Direct) |
View |
| 2022-12-07 Option Award |
2022-12-09 09:01 am |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Link David Charles Director |
41,493 | $1.205 | 98,806 (Direct) |
View |
| 2022-09-13 Option Award |
2022-09-15 5:15 pm |
N/A 2032-09-13 |
SAB Biotherapeutics Inc. | SABS | Reich Samuel J Executive Chairman |
525,000 | $0 | 525,000 (Direct) |
View |
| 2022-09-13 Option Award |
2022-09-15 5:15 pm |
N/A 2032-09-13 |
SAB Biotherapeutics Inc. | SABS | Sullivan Eddie Joe CHIEF EXECUTIVE OFFICER 10% Owner |
35,000 | $0 | 35,000 (Direct) |
View |
| 2022-09-13 Option Award |
2022-09-15 5:00 pm |
N/A 2032-09-13 |
SAB Biotherapeutics Inc. | SABS | Giberson Scott Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-09-13 Option Award |
2022-09-15 5:00 pm |
N/A 2032-09-13 |
SAB Biotherapeutics Inc. | SABS | Kropotova Alexandra Chief Medical Officer |
18,325 | $0 | 18,325 (Direct) |
View |
| 2022-09-13 Option Award |
2022-09-15 4:45 pm |
N/A 2032-09-13 |
SAB Biotherapeutics Inc. | SABS | Bausch Christoph Lawrence CHIEF OPERATING OFFICER |
274,875 | $0 | 274,875 (Direct) |
View |
| 2022-09-13 Option Award |
2022-09-15 4:45 pm |
N/A 2032-09-13 |
SAB Biotherapeutics Inc. | SABS | Beyer Russell P CHIEF FINANCIAL OFFICER |
274,875 | $0 | 274,875 (Direct) |
View |
| 2022-06-06 Option Award |
2022-06-07 8:00 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Kropotova Alexandra Chief Medical Officer |
300,000 | $0 | 300,000 (Direct) |
View |
| 2022-05-20 Other |
2022-05-23 5:52 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Spragens Jeffrey G Director |
299,002 | $0 | 611,004 (Direct) |
View |
| 2022-05-20 Other |
2022-05-23 5:45 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Reich Samuel J Executive Chairman |
2,707,128 | $0 | 3,462,827 (Indirect) |
View |
| 2022-03-16 Option Award |
2022-03-18 9:15 pm |
N/A 2033-03-16 |
SAB Biotherapeutics Inc. | SABS | Sullivan Eddie Joe Chief Executive Officer 10% Owner |
21,218 | $0 | 21,218 (Direct) |
View |
| 2022-03-16 Option Award |
2022-03-18 9:15 pm |
N/A 2032-03-16 |
SAB Biotherapeutics Inc. | SABS | Beyer Russell P Chief Financial Officer |
6,000 | $0 | 6,000 (Direct) |
View |
| 2022-03-16 Option Award |
2022-03-18 9:15 pm |
N/A 2032-03-16 |
SAB Biotherapeutics Inc. | SABS | Luke Thomas Charles Chief Medical Officer |
20,519 | $0 | 20,519 (Direct) |
View |
| 2022-03-16 Option Award |
2022-03-18 9:15 pm |
N/A 2032-03-16 |
SAB Biotherapeutics Inc. | SABS | Finnegan Frederick Chief Business Officer |
23,453 | $0 | 23,453 (Direct) |
View |
| 2022-03-16 Option Award |
2022-03-18 9:15 pm |
N/A 2032-03-16 |
SAB Biotherapeutics Inc. | SABS | Reich Samuel J Executive Chairman |
7,000 | $0 | 7,000 (Direct) |
View |
| 2022-03-16 Option Award |
2022-03-18 9:15 pm |
N/A 2032-03-16 |
SAB Biotherapeutics Inc. | SABS | Ullerich Melissa Vera Chief Communications Officer |
16,405 | $0 | 16,405 (Direct) |
View |
| 2022-03-16 Option Award |
2022-03-18 9:15 pm |
N/A 2032-03-16 |
SAB Biotherapeutics Inc. | SABS | Pommer Jerry Lynn Chief Compliance Officer |
15,172 | $0 | 15,172 (Direct) |
View |
| 2022-03-16 Option Award |
2022-03-18 9:15 pm |
N/A 2032-03-16 |
SAB Biotherapeutics Inc. | SABS | Bausch Christoph Lawrence Chief Science Officer |
24,972 | $0 | 24,972 (Direct) |
View |
| 2022-03-16 Option Award |
2022-03-18 9:15 pm |
N/A 2032-03-16 |
SAB Biotherapeutics Inc. | SABS | Erickson Bruce Kipp Chief Operating Officer |
18,196 | $0 | 18,196 (Direct) |
View |
| 2021-10-22 Option Award(A) |
2021-11-24 7:37 pm |
N/A 2027-03-12 |
SAB Biotherapeutics Inc. | SABS | Bausch Christoph Lawrence Chief Science Officer |
294,200 | $0 | 294,200 (Direct) |
View |
| 2021-10-22 Option Award(A) |
2021-11-22 2:31 pm |
N/A 2031-01-01 |
SAB Biotherapeutics Inc. | SABS | Polvino William James Director |
151,333 | $0 | 151,333 (Direct) |
View |
| 2021-11-17 Option Award |
2021-11-19 4:45 pm |
N/A 2031-11-17 |
SAB Biotherapeutics Inc. | SABS | Beyer Russell P Chief Financial Officer |
110,000 | $0 | 110,000 (Direct) |
View |
| 2021-11-17 Option Award |
2021-11-19 4:05 pm |
N/A 2031-11-17 |
SAB Biotherapeutics Inc. | SABS | Reich Samuel J Executive Chairman |
350,000 | $0 | 350,000 (Direct) |
View |
| 2021-09-28 Option Award |
2021-11-16 3:09 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Beyer Russell P Chief Financial Officer |
159 | $10.08 | 2,490 (Indirect) |
View |
| 2021-10-18 Option Award |
2021-11-16 3:09 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Beyer Russell P Chief Financial Officer |
2,475 | $10.1 | 2,490 (Direct) |
View |
| 2021-09-28 Option Award |
2021-11-16 3:09 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Beyer Russell P Chief Financial Officer |
5 | $10.07 | 2,490 (Indirect) |
View |
| 2021-10-25 Option Award |
2021-11-16 3:09 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Beyer Russell P Chief Financial Officer |
129 | $7.78 | 2,490 (Indirect) |
View |
| 2021-10-22 Option Award |
2021-10-26 9:53 pm |
N/A 2031-05-27 |
SAB Biotherapeutics Inc. | SABS | Carillo Carlos N SVP Regulatory Affairs |
17,681 | $0 | 17,681 (Direct) |
View |
| 2021-10-22 Option Award |
2021-10-26 9:53 pm |
N/A 2031-05-27 |
SAB Biotherapeutics Inc. | SABS | Erickson Bruce Kipp Chief Operating Officer |
232,642 | $0 | 232,642 (Direct) |
View |